Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioexcel Publishing
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/107426/1/107426.pdf |